The production of interferon (IFN) was investigated in human peripheral lymphocyte cultures stimulated by mumps virus. IFN-ca and IFN-y were produced in lymphocyte cultures from immune donors. However, no IFN--y Was produced in lymphocyte cultures from nonimmune donors. IFN-a was produced by B lymphocytes, and IFN--y was produced by T lymphocytes. An increase in the production of IFN--y resulted from the mixture of autologous macrophages in Tlymphocyte cultures. The production of IFN--y by T lymphocytes was found to depend on prior, possibly cellular, immunity.
Interferon (IFN) has been classified into three types, a, ,B, and -y (8) . IFN-a and -,B are known to be acid stable and can be induced by some viruses, polyinosine:polycytosine, and other inducers (7) . IFN--y is acid labile, is not neutralized by anti-IFN-ot and anti-IFN-, serum (7) , and can be induced by the stimulation of nonspecific mitogens (4, 24, 25) and specific antigens (2, 3, 5, 6, 17, 20, 22) . Immune-specific IFN production was found by Green et al. (5) in response to stimulation by purifled protein derivative. Youngner and Salvin (27) IFN-y (8) . In the case of specific viral antigens, IFN--y was produced by stimulation with herpes simplex virus (6, 17, 22) , cytomegalovirus (20) , and vaccinia virus (3).
Valle et al. (22) showed that IFN--y was produced by T cells stimulated by herpes simplex virus and that production was increased when both macrophages and lymphocytes were present.
Recently, Kato and Minagawa (11) reported that IFN-a, but not IFN-y, was produced in human lymphocyte cultures from seropositive donors in response to mumps virus. Similar results were reported with influenza A virus (12) and varicella-zoster virus (9) . These results seem to suggest that not all viruses induce IFN--y in immune response.
In this report, IFN production in response to mumps virus was investigated in human lymphocyte cutlures, and results different from those of Kato and Minagawa (11) ture. The effluent fraction, cleared of macrophages and dead cells, was centrifuged at 1,000 rpm for 10 min. Cells resuspended in 2 ml of warm medium were poured onto the nylon wool column, and this step was followed by adding 2 ml of warm medium. The column was incubated at 37°C for 45 min and then washed slowly with 30 ml of warm medium. For elution of nylon wool-adherent cells, the nylon wool was pressed and squeezed and then washed with 8 ml of warm medium. The cells obtained were centrifuged at 1,000 rpm at 4°C for 10 min and suspended in RPMI 1640 medium supplemented with 2% FCS. After this procedure, the effluent cells consisted largely of T cells and non-B-non-T cells, and the adherent cells consisted of B cells (10, 13, 21 
RESULTS
Effects of UV irradiation on the biological activities of mumps virus. The effect of UV irradiation on infectivity, IFN-inducing activity, and interfering activity with VSV are shown in Fig. 1 . Live mumps virus contained 1.6 x 107 TCID50 per ml, but infectivity was lost after 20 s of UV irradiation. To investigate the effect of UV irradiation on IFN-inducing activity, Namalva cells were adjusted to 106 per ml and stimulated with 0.1 ml of UV-irradiated mumps virus. After 3 days, culture supernatants were harvested, treated at pH 2, and assayed for IFN. Live mumps virus induced 60 U of IFN, and after 80 s of UV irradiation, all IFN-inducing activity was lost in Namalva cells.
If any mumps virus remained in the lymphocyte culture supernatants, the interference of mumps virus with VSV might have given a false IFN titer. Consequently, the interfering activity was examined as follows. Serial fourfold dilutions of mumps virus were placed on FL cells and followed by the same method as the IFN assay. Live mumps virus interfered with the cytopathic effect of VSV in FL cells, even in a >128-fold dilution. However, mumps virus irradiated by UV for 80 s had no interfering activity.
Therefore, an 80-s dose of UV irradiation was used in subsequent experiments to inactivate mumps virus. IFN Kinetics of IFN production. Two immune donors were investigated, and the results are shown in Fig. 2 . Lymphocytes were stimulated with 0.2 ml of UV-inactivated mumps virus by the method described above. Peak IFN production was reached on day 5 or 7. Acid-labile IFN was produced within 24 h, and an increase of acid-labile IFN production was observed between 3 and 5 days in donor 7 but not in donor 6.
Cellular sources of IFN. IFN production in Tcell and B-cell fractions separated by SRBC rosette formation are shown in These results show that acid-stable IFN is produced by B cells, acid-labile IFN is produced by T cells, and the mixture of autologous macrophages increases the production of acid-labile IFN by T cells in response to stimulation with UV-inactivated mumps virus.
Neutralization test of IFN. Rosette-forming cells from donor 9 were adjusted to 8 x 106 per ml and stimulated with 0.2 ml of UV-inactivated mumps virus (Table 2) . A 128-U amount of IFN was induced; it was reduced to 16 U after treatment at pH 2. This IFN preparation was used for neutralization tests. The results are shown in Table 4 (5) reported immune-specific IFN production for the first time. They reported that lymphocytes from tuberculin-sensitive donors produced IFN--y on exposure to purified protein derivative and that IFN production was maximum during days 4 to 7 of stimulation. Epstein et al. (2) also reported that the peak transformation for stimulation with purified protein derivative occurred on days 4 to 6, and peak IFN production occurred on days 7 to 8 after stimulation. The addition of macrophages to purified protein derivative-sensitized lymphocytes resulted in a more than threefold increase in IFN production.
Immune-specific IFN production in response to stimulation with herpes simplex virus was reported by Valle et al. (22) and by others (6, 17) . Valle et al. (22) reported that IFN--y production by combined macrophage-lymphocyte cultures was shown to depend on the presence of T cells. This IFN was relatively unstable at pH 2 and at 56°C, and the antigenicity was different from that of classical IFN (23) .
In the case of stimulation with cytomegalovirus (20) and vaccinia virus (3), IFN--y production was also reported.
Duc-Nguyen and Henle (1) reported that human peripheral lymphocytes supported, to some extent, the replication of mumps virus in the presence of phytohemagglutinin. McFarland et al. (15) reported that, in immune donors, a virusspecific proliferative response was elicited and occurred in T cells; more specifically, it oc-VOL. 40, 1983 on September 29, 2017 by guest http://iai.asm.org/ duced IFN-y. For example, the T cells obtained from donor 11, shown in Table 3 , did not produce IFN-y, even after the addition of macrophages. Lymphocytes from an individual who had had mumps 50 years before also did not produce IFN--y, but after reimmunization with mumps vaccine, lymphocytes from the same individual produced a high titer of IFN-y (data not shown). Significant amounts of IFN--y were produced in donor 9, who was infected with mumps recently.
These results strongly suggest that the production of IFN-y by T cells depends on the magnitude of immunity, possibly cellular immunity. This hypothesis may explain the difference of our results from those of Kato and Minagawa (11) .
Our results agree with those of Valle et al. (22) and Rasmussen et al. (17) . IFN-y production is evaluated as a mediator of cell-mediated immunity. The migration of immune lymphocytes into the infected area and subsequent immune-specific IFN-y production would play a significant role in host defense mechanisms.
